AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
14.55
-0.45 (-3.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
AnaptysBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 57.17 | 17.16 | 10.29 | 63.18 | 75 | 8 | Upgrade
|
Revenue Growth (YoY) | 282.17% | 66.78% | -83.72% | -15.77% | 837.50% | 60.00% | Upgrade
|
Cost of Revenue | 154.78 | 132.28 | 88.8 | 98.5 | 80.03 | 99.34 | Upgrade
|
Gross Profit | -97.6 | -115.13 | -78.51 | -35.32 | -5.03 | -91.34 | Upgrade
|
Selling, General & Admin | 42.47 | 41.95 | 33.44 | 21.49 | 18.85 | 16.09 | Upgrade
|
Operating Expenses | 42.47 | 41.95 | 33.44 | 21.49 | 18.85 | 16.09 | Upgrade
|
Operating Income | -140.08 | -157.07 | -111.95 | -56.81 | -23.88 | -107.43 | Upgrade
|
Interest Expense | -37.64 | -18.08 | -21.11 | -1.45 | - | -1.04 | Upgrade
|
Interest & Investment Income | 19.41 | 18.87 | 7.55 | 0.43 | 3.96 | 10.98 | Upgrade
|
Currency Exchange Gain (Loss) | -0.01 | - | - | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | 0.01 | 0.04 | -0.01 | 0 | Upgrade
|
EBT Excluding Unusual Items | -158.31 | -156.28 | -125.5 | -57.8 | -19.93 | -97.49 | Upgrade
|
Other Unusual Items | - | - | -3.2 | - | - | - | Upgrade
|
Pretax Income | -165.65 | -163.62 | -128.7 | -57.8 | -19.93 | -97.49 | Upgrade
|
Income Tax Expense | 0.01 | -0 | 0.02 | - | - | -0.15 | Upgrade
|
Net Income | -165.66 | -163.62 | -128.72 | -57.8 | -19.93 | -97.34 | Upgrade
|
Net Income to Common | -165.66 | -163.62 | -128.72 | -57.8 | -19.93 | -97.34 | Upgrade
|
Shares Outstanding (Basic) | 27 | 27 | 28 | 27 | 27 | 27 | Upgrade
|
Shares Outstanding (Diluted) | 27 | 27 | 28 | 27 | 27 | 27 | Upgrade
|
Shares Change (YoY) | 0.08% | -4.41% | 2.68% | 0.47% | 0.90% | 9.67% | Upgrade
|
EPS (Basic) | -6.04 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | Upgrade
|
EPS (Diluted) | -6.04 | -6.08 | -4.57 | -2.11 | -0.73 | -3.60 | Upgrade
|
Free Cash Flow | -103.39 | -121.61 | -73.95 | -47.29 | -14.73 | -70.32 | Upgrade
|
Free Cash Flow Per Share | -3.77 | -4.52 | -2.63 | -1.72 | -0.54 | -2.60 | Upgrade
|
Gross Margin | -170.72% | - | - | -55.91% | -6.70% | - | Upgrade
|
Operating Margin | -245.01% | -915.50% | -1088.31% | -89.93% | -31.84% | -1342.90% | Upgrade
|
Profit Margin | -289.75% | -953.66% | -1251.33% | -91.49% | -26.57% | -1216.70% | Upgrade
|
Free Cash Flow Margin | -180.84% | -708.79% | -718.88% | -74.85% | -19.63% | -879.03% | Upgrade
|
EBITDA | -139.45 | -156.42 | -111.28 | -56.2 | -23.32 | -106.92 | Upgrade
|
EBITDA Margin | -243.91% | - | - | -88.95% | -31.09% | - | Upgrade
|
D&A For EBITDA | 0.63 | 0.65 | 0.68 | 0.62 | 0.56 | 0.51 | Upgrade
|
EBIT | -140.08 | -157.07 | -111.95 | -56.81 | -23.88 | -107.43 | Upgrade
|
EBIT Margin | -245.01% | - | - | -89.93% | -31.84% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.